Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
BAYZED HEALTH
02609.HK
Bayzed Health Group Inc operates and manages a network of hospitals that provides oncology medical and healthcare services in the People’s Republic of China. The company offers screening, diagnosis, treatment, and rehabilitation services. It also provides hospital management services; and supplies pharmaceuticals, medical equipment, and consumables. The company was founded in 2017 and is headquartered in Beijing, the People’s Republic of China.Bayzed Healthcare Investment Group Co., Ltd.
33.46 B
02609.HKMarket value -Rank by Market Cap -/-

Financial Score

09/02/2026 Update
C
Health Care FacilitiesIndustry
Industry Ranking3/18
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-2.28%D
    • Profit Margin-2.48%D
    • Gross Margin18.50%D
  • Growth ScoreC
    • Revenue YoY4.80%C
    • Net Profit YoY-58.92%D
    • Total Assets YoY21.71%A
    • Net Assets YoY42.33%A
  • Cash ScoreD
    • Cash Flow Margin-4038.85%E
    • OCF YoY4.80%C
  • Operating ScoreC
    • Turnover0.49C
  • Debt ScoreB
    • Gearing Ratio38.79%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Morning Trend | BAYZED HEALTH is building a bottom and consolidating, is a low-level fluctuation and intraday movement coming?

    On February 3rd, BAYZED HEALTH (2609.HK) maintained a low-volume fluctuation throughout the day, with the bottom consolidation pattern still in place. The medical services sector lacked favorable policies this week, and mainstream funds are generally waiting for more precise guidance. Short-term focus is on whether the bottom consolidation area can attract support, with some funds testing low absorption during the session. Technical indicators are also weak, with the daily MACD death cross signal continuing to amplify and the KDJ approaching the oversold area. Intraday trading is mainly characterized by internal rotation of existing stocks, with major funds not significantly increasing their positions, resulting in sluggish trading. There is heated discussion in the community about potential catalysts from upcoming new mergers or cooperation events, but previous small cooperation news has already been largely digested. Operational advice: If intraday trading volume surges or significant industry news materializes, a short-term rebound may be initiated; otherwise, weak consolidation will dominate. Observers can continue to track bottom fund behavior and anomalies, and short-term risk management should be prioritized to strictly control loss exposure. Only when the market shows signs of warming can one consider positioning for a right-side trend

    Technical Forecast·
    Technical Forecast·